KZR vs PAYC · $53.9M cap vs P/E 33, rev $1.10B
Kezar Life Sciences Inc (KZR) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Latest reported PAYC revenue for 2026-06-30 was $1.10B. Net income was $263.1M. Revenue was up 92.9% from 2026-03-31 to 2026-06-30. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
KZR currently screens at market cap $53.9M. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the KZR and PAYC stock pages for the full models.
Not investment advice.